Stay updated on Apitegromab Long-Term Safety & Efficacy in SMA Clinical Trial
Sign up to get notified when there's something new on the Apitegromab Long-Term Safety & Efficacy in SMA Clinical Trial page.

Latest updates to the Apitegromab Long-Term Safety & Efficacy in SMA Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has updated its version from v2.14.4 to v2.15.0, indicating a significant revision. The phrase 'Here’s how you know' has been removed and replaced with a similar phrase, which does not alter the core content.SummaryDifference1.0%
- Check39 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 20, 2025.SummaryDifference1.0%
- Check82 days agoChange DetectedThe page now includes a new date for the long-term safety and efficacy study of Apitegromab, moving it to February 20, 2025, while a previous date of July 29, 2024, has been removed.SummaryDifference6%
- Check97 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check104 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
Stay in the know with updates to Apitegromab Long-Term Safety & Efficacy in SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apitegromab Long-Term Safety & Efficacy in SMA Clinical Trial page.